4.7 Article

Neuropilin-1 regulated by miR-320 contributes to the growth and metastasis of cholangiocarcinoma cells

Related references

Note: Only part of the references are listed.
Article Oncology

A Multicenter Phase II Study of Gemcitabine, Capecitabine, and Bevacizumbab for Locally Advanced or Metastatic Biliary Tract Cancer

Renuka V. Iyer et al.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2018)

Article Pathology

Neuropilin 1 Receptor Is Up-Regulated in Dysplastic Epithelium and Oral Squamous Cell Carcinoma

Shokoufeh Shahrabi-Farahani et al.

AMERICAN JOURNAL OF PATHOLOGY (2016)

Article Oncology

Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122

Huaqiang Zhu et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)

Article Biochemistry & Molecular Biology

Targeting c-MET by LY2801653 for treatment of cholangiocarcinoma

Samarpita Barat et al.

MOLECULAR CARCINOGENESIS (2016)

Article Oncology

MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1

Radhakrishnan Vishnubalaji et al.

ONCOTARGET (2016)

Article Cell Biology

Integrin endosomal signalling suppresses anoikis

Jonna Alanko et al.

NATURE CELL BIOLOGY (2015)

Article Gastroenterology & Hepatology

FAK Is Required for c-Met/beta-Catenin-Driven Hepatocarcinogenesis

Na Shang et al.

HEPATOLOGY (2015)

Article Gastroenterology & Hepatology

Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma

John Bridgewater et al.

JOURNAL OF HEPATOLOGY (2014)

Article Multidisciplinary Sciences

Constitutive and ligand-induced EGFR signalling triggers distinct and mutually exclusive downstream signalling networks

Sharmistha Chakraborty et al.

NATURE COMMUNICATIONS (2014)

Review Pharmacology & Pharmacy

Targeting VEGF signalling via the neuropilin co-receptor

Snezana Djordjevic et al.

DRUG DISCOVERY TODAY (2013)

Article Oncology

Neuropilin-1-Dependent Regulation of EGF-Receptor Signaling

Sabrina Rizzolio et al.

CANCER RESEARCH (2012)

Review Pharmacology & Pharmacy

Targeting the VEGF signaling pathway in cancer therapy

Maximilian J. Waldner et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2012)

Article Immunology

Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth

Petra Hamerlik et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2012)

Article Cell Biology

Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320

A. Bronisz et al.

NATURE CELL BIOLOGY (2012)

Article Oncology

VEGF Inhibition, Hypertension, and Renal Toxicity

Suzanne R. Hayman et al.

CURRENT ONCOLOGY REPORTS (2012)

Article Gastroenterology & Hepatology

Neuropilin-1 is upregulated in hepatocellular carcinoma and contributes to tumour growth and vascular remodelling

Mathieu Berge et al.

JOURNAL OF HEPATOLOGY (2011)

Review Gastroenterology & Hepatology

Clinical diagnosis and staging of cholangiocarcinoma

Boris Blechacz et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)

Article Medicine, General & Internal

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer.

Juan Valle et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Gastroenterology & Hepatology

The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma

Lei Chen et al.

JOURNAL OF HEPATOLOGY (2009)